As the genetic testing market continues to grow exponentially in size and cost, the challenge of determining which genetic tests may produce results that effectively guide treatment decisions is becoming increasingly difficult for health plans lacking the expertise and technology to efficiently manage utilization and lab spending.

In Chapter 2 of Transforming the Management of Genetic Testing, we discuss the critical role of science-backed, evidence-based lab policies in genetic test management systems and an improved, next-generation solution to ensure the right test is ordered to inform the right care at the right time.